Bridgeway Capital Management’s CalciMedica CALC Stock Holding History

Bridgeway Capital Management’s Portfolio CALC Stock Details CALC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-2,993	Closed	-$20.9K	–	1384
2022 Q4	$20.9K	Sell	2,993 -1,578	-35%	-$17.7K	﹤0.01%	1339
2022 Q3	$60K	Sell	4,571 -3,572	-44%	-$50.6K	﹤0.01%	1335
2022 Q2	$124K	Sell	8,143 -857	-10%	-$11.7K	﹤0.01%	1189
2022 Q1	$155K	Buy	9,000 +2,571	+40%	+$49K	﹤0.01%	1207
2021 Q4	$165K	Hold	6,429	–	–	﹤0.01%	1178
2021 Q3	$299K	Buy	+6,429	New	+$361K	0.01%	1159
2021 Q2	–	Sell	-2,714	Closed	-$211K	–	1341
2021 Q1	$211K	Buy	+2,714	New	+$812K	﹤0.01%	1281

Bridgeway Capital Management's CALC Position: Q1 2023 in Review

Bridgeway Capital Management sold out of CalciMedica (CALC) in Q1 2023, closing a stake of 2,993 shares — an estimated $20.9K sold.

Bridgeway Capital Management first reported a position in CALC in Q1 2021 and held it in 7 quarters. The position peaked at $299K in Q3 2021. 0 funds tracked by Wall St. Rank hold CALC as of Q1 2023.

Bridgeway Capital Management reported no remaining CalciMedica position as of Q1 2023 after selling out during the quarter.
Bridgeway Capital Management sold 2,993 CalciMedica shares in Q1 2023, an estimated $20.9K.
Bridgeway Capital Management first reported a position in CalciMedica in Q1 2021 and held it in 7 quarters.
Bridgeway Capital Management's CalciMedica position peaked at $299K in Q3 2021.
0 funds tracked by Wall St. Rank held CalciMedica as of Q1 2023.

Based on Bridgeway Capital Management's 13F filing for Q1 2023, filed 15 May 2023.